drugset / Trial / NCT00186277
Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To combine oxaliplatin and taxotere in patients who have had prior cisplatin therapy in bladder cancer.
Timeline
- Start
- 2003-12
- Primary completion
- 2006-12
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | — |
| Subject | Oxaliplatin | Small molecule | — | — |